The average selling price for ASPIREHC in Sweden grew in 2022, according to GlobalData. The average selling price, the complete price range of high and low prices and a 3-year forecast for the ASPIREHC device in Sweden can be viewed in GlobalData’s micro pricing report. Buy the report here.
The ASPIREHC is sold by Livanova in the Vagus Nerve Stimulators market. A Vagus Nerve Stimulator (VNS) is a device comprised of an electrical pacemaker that sends electrical stimulation through surgically-implanted electrodes to target the vagus nerve. VNSs are utilized to treat neurological disorders like epilepsy and depression.
Factors contributing to the list price of a medical device include but are not limited to therapy area, complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. Moreover, final selling prices vary geographically and by facility type. These prices are further subject to discounts, as well as purchasing and distribution agreements.
For a complete picture of Livanova’ Vagus Nerve Stimulators device pricing in Sweden, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.